Qingcheng Mao

5.4k total citations · 1 hit paper
82 papers, 4.3k citations indexed

About

Qingcheng Mao is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Qingcheng Mao has authored 82 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 38 papers in Pediatrics, Perinatology and Child Health and 18 papers in Molecular Biology. Recurrent topics in Qingcheng Mao's work include Drug Transport and Resistance Mechanisms (52 papers), Pharmacological Effects and Toxicity Studies (28 papers) and Pregnancy and Medication Impact (17 papers). Qingcheng Mao is often cited by papers focused on Drug Transport and Resistance Mechanisms (52 papers), Pharmacological Effects and Toxicity Studies (28 papers) and Pregnancy and Medication Impact (17 papers). Qingcheng Mao collaborates with scholars based in United States, Canada and United Kingdom. Qingcheng Mao's co-authors include Jashvant D. Unadkat, Susan P.C. Cole, Roger G. Deeley, Zhanglin Ni, Anshul Gupta, Mark F. Rosenberg, Zsolt Bikádi, Honggang Wang, Yi Zhang and Lin Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Qingcheng Mao

81 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update

2014 506 citations Qingcheng Mao, Jashvant D. Unadkat profile →

Peers

Qingcheng Mao

ONCOL

MB

PPCH

PHEOH

ND

Rocı́o I.R. Macı́as Spain

Douglas D. Ross United States

Satohiro Masuda Japan

Anne T. Nies Germany

Sook Wah Yee United States

Inka Leier Germany

Yunhai Cui Germany

María J. Monte Spain

Csilla Özvegy‐Laczka Hungary

Yurong Lai United States

Rocı́o I.R. Macı́as Spain

Qingcheng Mao

2.4k ×0.9

ONCOL

1.3k ×0.9

MB

653 ×0.5

PPCH

537 ×0.8

PHEOH

221 ×0.5

ND

Citations per year, relative to Qingcheng Mao Qingcheng Mao (= 1×) peers Rocı́o I.R. Macı́as

Countries citing papers authored by Qingcheng Mao

Since Specialization

Citations

This map shows the geographic impact of Qingcheng Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingcheng Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingcheng Mao more than expected).

Fields of papers citing papers by Qingcheng Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingcheng Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingcheng Mao. The network helps show where Qingcheng Mao may publish in the future.

Co-authorship network of co-authors of Qingcheng Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Qingcheng Mao. A scholar is included among the top collaborators of Qingcheng Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingcheng Mao. Qingcheng Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chen, Xin, Zsuzsanna Gáborik, Qingcheng Mao, & Jashvant D. Unadkat. (2024). Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?. International Journal of Molecular Sciences. 25(22). 12036–12036. 1 indexed citations

2.

Correia‐Branco, Ana, S Pillai, Alison G. Paquette, et al.. (2023). SLC20a1/PiT-1 is required for chorioallantoic placental morphogenesis. SHILAP Revista de lepidopterología. 5(1). 3 indexed citations

3.

Unadkat, Jashvant D., et al.. (2023). Regulation of Human Renal Drug Transporter mRNA Expression by Proinflammatory Cytokines. Journal of Pharmacology and Experimental Therapeutics. 385. 583–583. 1 indexed citations

4.

Chen, Xin, Jashvant D. Unadkat, & Qingcheng Mao. (2022). Maternal and Fetal Exposure to (-)-Δ9-tetrahydrocannabinol and Its Major Metabolites in Pregnant Mice Is Differentially Impacted by P-glycoprotein and Breast Cancer Resistance Protein. Drug Metabolism and Disposition. 51(3). 269–275. 6 indexed citations

5.

Chen, Xin, Jashvant D. Unadkat, & Qingcheng Mao. (2021). Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2). Drug Metabolism and Disposition. 49(10). 910–918. 17 indexed citations

6.

Wang, Lu, Yuanyuan Shi, Joseph L. Dempsey, et al.. (2020). Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy. Drug Metabolism and Disposition. 48(8). 708–722. 9 indexed citations

7.

Gao, Chunying, et al.. (2018). Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract. Drug Metabolism and Disposition. 46(5). 581–591. 26 indexed citations

8.

Chang, Shih‐Yu, Elijah J. Weber, Viktoriya S. Sidorenko, et al.. (2017). Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight. 2(22). 138 indexed citations

9.

Liao, Michael Z., Chunying Gao, Laura M. Shireman, et al.. (2017). P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine. Pharmacological Research. 119. 61–71. 24 indexed citations

10.

Rosenberg, Mark F., Zsolt Bikádi, Eszter Hazai, et al.. (2015). Three-dimensional structure of the human breast cancer resistance protein (BCRP/ABCG2) in an inward-facing conformation. Acta Crystallographica Section D Biological Crystallography. 71(8). 1725–1735. 32 indexed citations

11.

Risler, Linda J., Kenneth Rice, Danny D. Shen, et al.. (2014). Maternal-Fetal Disposition of Glyburide in Pregnant Mice Is Dependent on Gestational Age. Journal of Pharmacology and Experimental Therapeutics. 350(2). 425–434. 14 indexed citations

12.

Rosenberg, Mark F., Zsolt Bikádi, Xiaoping Liu, et al.. (2010). The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone. Structure. 18(12). 1688–1689. 3 indexed citations

13.

Rosenberg, Mark F., Curtis Oleschuk, Peng Wu, et al.. (2010). Structure of a human multidrug transporter in an inward-facing conformation. Journal of Structural Biology. 170(3). 540–547. 20 indexed citations

14.

Rosenberg, Mark F., Zsolt Bikádi, Xiaoping Liu, et al.. (2010). The Human Breast Cancer Resistance Protein (BCRP/ABCG2) Shows Conformational Changes with Mitoxantrone. Structure. 18(4). 482–493. 71 indexed citations

15.

Cai, Xiaokun, Zsolt Bikádi, Zhanglin Ni, et al.. (2010). Role of Basic Residues within or near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein in Drug Transport. Journal of Pharmacology and Experimental Therapeutics. 333(3). 670–681. 26 indexed citations

16.

Zhang, Yi, Anshul Gupta, Honggang Wang, et al.. (2005). BCRP Transports Dipyridamole and is Inhibited by Calcium Channel Blockers. Pharmaceutical Research. 22(12). 2023–2034. 97 indexed citations

17.

Mao, Qingcheng, Wei Qiao Qiu, Peter A. Lander, et al.. (2002). GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776. Journal of Biological Chemistry. 277(32). 28690–28699. 50 indexed citations

18.

Leslie, Elaine M., Qingcheng Mao, Curtis Oleschuk, Roger G. Deeley, & Susan P.C. Cole. (2001). Modulation of Multidrug Resistance Protein 1 (MRP1/ABCC1) Transport and ATPase Activities by Interaction with Dietary Flavonoids. Molecular Pharmacology. 59(5). 1171–1180. 191 indexed citations

19.

Mao, Qingcheng, Roger G. Deeley, & Susan P.C. Cole. (2000). Functional Reconstitution of Substrate Transport by Purified Multidrug Resistance Protein MRP1 (ABCC1) in Phospholipid Vesicles. Journal of Biological Chemistry. 275(44). 34166–34172. 84 indexed citations

20.

Hipfner, David R., Qingcheng Mao, Wei Qiao Qiu, et al.. (1999). Monoclonal Antibodies That Inhibit the Transport Function of the 190-kDa Multidrug Resistance Protein, MRP. Journal of Biological Chemistry. 274(22). 15420–15426. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact